| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3943933 | Gynecologic Oncology | 2012 | 7 Pages |
ObjectiveWithaferin A, a natural withanolide, has shown anti-cancer properties in various cancers including breast cancer, but its effects in ovarian cancer remain unexplored. Notch 1 and Notch3 are critically involved in ovarian cancer progression. We decided to examine the effects of Withaferin A in ovarian carcinoma cell lines and its molecular mechanism of action including its regulation of Notch.MethodsThe effects of Withaferin A were examined in CaOV3 and SKOV3 ovarian carcinoma cell lines using MTS assay, clonogenic assay, annexin V/propidium iodide flow cytometry, and cell cycle analysis. Western analysis was conducted to examine the molecular mechanisms of action.ResultsWithaferin A inhibited the growth and colony formation of CaOV3 and SKOV3 cells by inducing apoptosis and cell cycle arrest. These changes correlated with down-regulation of Notch1, Notch3, cdc25C, total and phosphorylated Akt, and bcl-2 proteins.ConclusionsWithaferin A inhibits CaOV3 and SKOV3 ovarian carcinoma cell growth, at least in part by targeting Notch1 and Notch3.
► We investigated the effects of a natural withanolide Withaferin A in CaOV3 and SKOV3 ovarian carcinoma cell lines. ► Withaferin A induces cell cycle arrest and apoptosis in both CaOV3 and SKOV3 cells, and down-regulates the Notch/Akt/bcl-2 pathways. ► Withaferin A is a potential therapeutic agent for ovarian cancer.
